Ana Ortiz de Mendivil

Dr. Ana Ortiz de Mendivil

Neuroradiology, HM Hospitales, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
NGNoemi Garcia
Noemi Garcia
JCJosefa Carrión-Navarro
Josefa Carrión-Navarro
SESusana Esteban-Rubio
Susana Esteban-Rubio
ELElisa Lázaro-Ibáñez
Elisa Lázaro-Ibáñez
MPMaría Peris-Celda
María Peris-Celda
ÁAÁngel Ayuso-Sacido
Ángel Ayuso-Sacido
DNA sequences within glioma-derived extracellular vesicles can cross the intact Blood-Brain Barrier and be detected in peripheral blood of patients

20 January 2021 in Cells
Verified
Journal Article
Open access
PDF file
Tomás DurajTomás Duraj
Tomás Duraj
NGNoemi Garcia
Noemi Garcia
PCPepa Carrion-Navarro
Pepa Carrion-Navarro
RMRodrigo Madurga
Rodrigo Madurga
Ana Ortiz de MendivilAna Ortiz de Mendivil
Ana Ortiz de Mendivil
ÁAÁngel Ayuso-Sacido
Ángel Ayuso-Sacido
Glioblastoma (GBM) is the most aggressive primary brain tumor, with a median survival at diagnosis of 16–20 months. Metabolism represents a new attractive therapeutic target; however, due to high intratumoral heterogeneity, the application of metabolic drugs in GBM is challenging. We characterized the basal bioenergetic metabolism and antiproliferative potential of metformin (MF), dichloroacetate (DCA), sodium oxamate (SOD) and diazo-5-oxo-L-norleucine (DON) in three distinct glioma stem cells (GSCs) (GBM18, GBM27, GBM38), as well as U87MG. GBM27, a highly oxidative cell line, was the most resistant to all treatments, except DON. GBM18 and GBM38, Warburg-like GSCs, were sensitive to MF and DCA, respectively. Resistance to DON was not correlated with basal metabolic phenotypes. In combinatory experiments, radiomimetic bleomycin exhibited therapeutically relevant synergistic effects with MF, DCA and DON in GBM27 and DON in all other cell lines. MF and DCA shifted the metabolism of treated cells towards glycolysis or oxidation, respectively. DON consistently decreased total ATP production. Our study highlights the need for a better characterization of GBM from a metabolic perspective. Metabolic therapy should focus on both glycolytic and oxidative subpopulations of GSCs.

1 April 2013 in Seminars in Ultrasound, CT and MRI
Verified
Journal Article
Closed access
Ana Ortiz de MendivilAna Ortiz de Mendivil
Ana Ortiz de Mendivil
AAAndrea Alcalá-Galiano
Andrea Alcalá-Galiano
MOMarta Ochoa
Marta Ochoa
ESElena Salvador
Elena Salvador
JMJosé M. Millán
José M. Millán

1 May 2016 in The Spine Journal
Verified
Journal Article
Closed access
EAEstanislao Arana
Estanislao Arana
Francisco M KovacsFrancisco M Kovacs
Francisco M Kovacs
ARAna Royuela
Ana Royuela
BABeatriz Asenjo
Beatriz Asenjo
ÚPÚrsula Pérez-Ramírez
Úrsula Pérez-Ramírez
IZIdoya Zazpe
Idoya Zazpe

14 April 2023 in Scientific Data
Verified
Journal Article
Open access
PDF file
BOBeatriz Ocaña-Tienda
Beatriz Ocaña-Tienda
JPJulián Pérez-Beteta
Julián Pérez-Beteta
JVJosé D. Villanueva-García
José D. Villanueva-García
JRJosé A. Romero-Rosales
José A. Romero-Rosales
DMDavid Molina-García
David Molina-García
Víctor M. Pérez-GarcíaVíctor M. Pérez-García
Víctor M. Pérez-García
Brain metastasis (BM) is one of the main complications of many cancers, and the most frequent malignancy of the central nervous system. Imaging studies of BMs are routinely used for diagnosis of disease, treatment planning and follow-up. Artificial Intelligence (AI) has great potential to provide automated tools to assist in the management of disease. However, AI methods require large datasets for training and validation, and to date there have been just one publicly available imaging dataset of 156 BMs. This paper publishes 637 high-resolution imaging studies of 75 patients harboring 260 BM lesions, and their respective clinical data. It also includes semi-automatic segmentations of 593 BMs, including pre- and post-treatment T1-weighted cases, and a set of morphological and radiomic features for the cases segmented. This data-sharing initiative is expected to enable research into and performance evaluation of automatic BM detection, lesion segmentation, disease status evaluation and treatment planning methods for BMs, as well as the development and validation of predictive and prognostic tools with clinical applicability.

25 December 2019 in Cancers
Verified
Journal Article
Open access
PDF file
NGNoemi Garcia
Noemi Garcia
PCPepa Carrion-Navarro
Pepa Carrion-Navarro
PAPilar Areal-Hidalgo
Pilar Areal-Hidalgo
Ana Ortiz de MendivilAna Ortiz de Mendivil
Ana Ortiz de Mendivil
AAAdrià Asensi-Puig
Adrià Asensi-Puig
ÁAÁngel Ayuso-Sacido
Ángel Ayuso-Sacido
Pediatric Central Nervous System (CNS) tumors are the most fatal cancer diseases in childhood. Due to their localization and infiltrative nature, some tumor resections or biopsies are not feasible. In those cases, the use of minimally invasive methods as diagnostic, molecular marker detection, prognostic or monitoring therapies are emerging. The analysis of liquid biopsies which contain genetic information from the tumor has been much more widely explored in adults than in children. We compare the detection of BRAF V600E targetable mutation by digital-PCR from cell-free-DNA and EV-derived DNA (ctDNA) in serum, plasma and cerebrospinal fluid (CSF) isolated from a cohort of 29 CNS pediatric patients. Here we demonstrate that ctDNA isolated from serum and plasma could be successfully analyzed to obtain tumor genetic information which could be used to guide critical treatment decisions.